Production of Well-Characterized Virus-like Particles in an Escherichia coli-Based Expression Platform for Preclinical Vaccine Assessments

Methods Mol Biol. 2016:1404:437-457. doi: 10.1007/978-1-4939-3389-1_29.

Abstract

In this chapter we demonstrate a method to produce virus-like particles (VLPs) from Escherichia coli. Standard bacterial protocols are used for the cloning, transformation, and expression of the protein subunits. A two-step protein purification method is highlighted: one step based on separating soluble proteins with ion-exchange affinity chromatography and a second polishing step using size-exclusion columns to isolate VLP species. The ensuing VLPs can be characterized with a variety of biophysical techniques including ultraviolet (UV)-visible spectroscopy for protein quantification, dynamic light scattering for size distribution determination, and transmission electron microscopy to ascertain size and morphology.

Keywords: Dynamic light scattering; Expression; Purification; Transmission electron microscopy; Ultraviolet (UV)–visible absorbance spectroscopy; Virus-like particles.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Capsid Proteins / genetics
  • Cloning, Molecular
  • Drug Evaluation, Preclinical
  • Dynamic Light Scattering
  • Escherichia coli / genetics*
  • Genetic Engineering / methods*
  • Microscopy, Electron, Transmission
  • Spectrophotometry, Ultraviolet
  • Transformation, Genetic
  • Vaccines, Virus-Like Particle / biosynthesis
  • Vaccines, Virus-Like Particle / chemistry
  • Vaccines, Virus-Like Particle / genetics*
  • Vaccines, Virus-Like Particle / isolation & purification

Substances

  • Capsid Proteins
  • Vaccines, Virus-Like Particle